[1]
T. Zadvornyi, “EXPRESSION OF OSTEOPONTIN AND OSTEONECTIN IN BREAST AND PROSTATE CANCER CELLS WITH DIFFERENT SENSITIVITY TO DOXORUBICIN”, Exp. oncol., vol. 44, no. 2, pp. 107–112, May 2023.